Pharmaceutical Intermediates Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
The global pharmaceutical intermediates market size was estimated to be US$ 29.5 billion in 2021 and is expected to grow at a CAGR of 7.2% between 2023 to 2032.
The raw materials that are used in the production of bulk drugs are known as pharmaceutical intermediates. They are produced during the synthesis of active pharmaceutical ingredient (API) as a byproduct. In the pharmaceutical and cosmetic industries they are widely used. Usually they are produced out of coal tar or petroleum but nowadays they are also produced by organic synthesis.
Pharmaceutical ingredients are used to produce pesticides, pharmaceuticals, plasticizers, additives and resins. Due the increase in research and development activities globally the demand for pharmaceutical ingredients is rapidly expanding.
Furthermore with the evolution in production technology and expanding international chemical industry, the demand for pharmaceutical intermediates around the world is growing. As they as basically intermediate products of certain products they are produced on demand for bulk and custom productions.
Pharmaceutical Intermediates Market Dynamics
Rising Prevalence of Chronic Diseases and Infectious Diseases
The rising demand to treat chronic diseases increases the requirements of pharmaceutical intermediates. Additionally the demand for APIs in the coming years will also rise due to surging prevalence of infectious diseases which in turn will bolster the growth of the global pharmaceutical intermediate market.
New treatment applications in cardiovascular disorders
Pharmaceutical intermediates are currently being used for treating cardiac disorders such as cardiac arrhythmia. Medical research and development will discover new applications of these intermediates and generate more lucrative opportunities in this market globally.
Increase in public and private healthcare expenditure
Due to an increasing demand for new drugs for COVID-19 and chronic diseases, there is an increase in funding for medical research activities and the growth of the market is certain. The growing awareness among the doctors and patients regarding chronic diseases and increase in public and private healthcare expenditure has further bolstered the market growth.
Pharmaceutical Intermediates Market Challenges
Complexities in Manufacturing
Manufacturing pharmaceutical intermediates is a costly process that requires significant investments, clinical trial expertise, quality systems, scientific standards and technical capabilities. Pharmaceutical intermediates manufacturers are required to invest in clinical trials and post-approval safety monitoring programs that are similar to that of original innovator companies.
Strict Government Regulations
Government regulators around the world have imposed various stringent regulations and standards pertaining to new pharmaceutical intermediate products which are expected to restrain market growth.
Side effects associated with intermediates
Many intermediates previously introduced have shown multiple adverse side effects and therefore have been not approved by the regulators. Such setbacks for the pharmaceutical intermediate manufacturers will further challenge the growth of this market globally.
Major companies profiled in the global pharmaceutical intermediates market are BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto, , Albemarle, Corporation, Vertellus, Chemcon Speciality Chemicals Ltd., Chiracon GmbH, Life Sciences Private Limited and others.
Pharmaceutical Intermediates Market Segmentation
By Product:
- Bulk Drug Intermediate
- Chiral Intermediate
- Achiral Intermediate
- Custom Intermediate
- Chemical Intermediate
By Application:
- Analgesics
- Anti-inflammatory Drug
- Cardiovascular Drugs
- Anti-diabetic Drugs
- Antimicrobial Drugs
- Anti-cancer Drugs
- Others
By End User:
- Pharmaceutical & Biotechnology Companies
- Reasearch Companies
- CROs & CMOs
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Brazil
- Rest of South America
- Introduction
- Research Objectives
- Report Assumptions
- Research Methodology
- Abbreviations
- Preface
- Market Definition
- Report Scope and Market Segmentation
- Research Highlights
- Market Synopsis: Global Pharmaceutical Intermediates Market
- Global Pharmaceutical Intermediates Market Qualitative Analysis
- Trends
- Market trends
- Technology Trends
- PESTLE Analysis (For 3 prominent countries)
- Market Influencers
- Driving Forces
- Hindering Forces
- Opportunities
- COVID-19 impact
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Trends
- Global Pharmaceutical Intermediates Market Analysis and Forecast, by Product
- Overview and definitions
- Key segment analysis
- Global Pharmaceutical Intermediates Market Estimates (US$ Mn), by Product, 2019 – 2032
- Chemical Intermediates
- Bulk Drug Intermediates
- Chiral Intermediates
- Achiral Intermediates
- Custom Intermediates
- Global Pharmaceutical Intermediates Market Analysis and Forecast, by Application
- Overview and definitions
- Key segment analysis
- Global Pharmaceutical Intermediates Market Estimates (US$ Mn), by Application, 2019 – 2032
- Analgesics
- Anti-inflammatory Drug
- Cardiovascular Drugs
- Anti-diabetic Drugs
- Antimicrobial Drugs
- Anti-cancer Drugs
- Others
- Global Pharmaceutical Intermediates Market Analysis and Forecast, by End User
- Overview and definitions
- Key segment analysis
- Global Pharmaceutical Intermediates Market Estimates (US$ Mn), by End User, 2019 – 2032
- Biotech and Pharma Companies
- Research Laboratory
- CMOs/CROs
- Global Pharmaceutical Intermediates Market Analysis and Forecast, by Region
- Overview and definitions
- Key segment analysis
- Global Pharmaceutical Intermediates Market Estimates (US$ Mn), by Region, 2019 – 2032
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
- North America Pharmaceutical Intermediates Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- North America Pharmaceutical Intermediates Market Estimates (US$ Mn), by Product, 2019 – 2032
- Chemical Intermediates
- Bulk Drug Intermediates
- Chiral Intermediates
- Achiral Intermediates
- Custom Intermediates
- North America Pharmaceutical Intermediates Market Estimates (US$ Mn), by Application, 2019 – 2032
- Analgesics
- Anti-inflammatory Drug
- Cardiovascular Drugs
- Anti-diabetic Drugs
- Antimicrobial Drugs
- Anti-cancer Drugs
- Others
- North America Pharmaceutical Intermediates Market Estimates (US$ Mn), by End User, 2019 – 2032
- Biotech and Pharma Companies
- Research Laboratory
- CMOs/CROs
- North America Pharmaceutical Intermediates Market Estimates (US$ Mn), by Country, 2019 – 2032
- United States
- Canada
- Rest of North America
- Europe Pharmaceutical Intermediates Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Europe Pharmaceutical Intermediates Market Estimates (US$ Mn), by Product, 2019 – 2032
- Chemical Intermediates
- Bulk Drug Intermediates
- Chiral Intermediates
- Achiral Intermediates
- Custom Intermediates
- Europe Pharmaceutical Intermediates Market Estimates (US$ Mn), by Application, 2019 – 2032
- Analgesics
- Anti-inflammatory Drug
- Cardiovascular Drugs
- Anti-diabetic Drugs
- Antimicrobial Drugs
- Anti-cancer Drugs
- Others
- Europe Pharmaceutical Intermediates Market Estimates (US$ Mn), by End User, 2019 – 2032
- Biotech and Pharma Companies
- Research Laboratory
- CMOs/CROs
- Europe Pharmaceutical Intermediates Market Estimates (US$ Mn), by Country, 2019 – 2032
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific Pharmaceutical Intermediates Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Asia Pacific Pharmaceutical Intermediates Market Estimates (US$ Mn), by Product, 2019 – 2032
- Chemical Intermediates
- Bulk Drug Intermediates
- Chiral Intermediates
- Achiral Intermediates
- Custom Intermediates
- Asia Pacific Pharmaceutical Intermediates Market Estimates (US$ Mn), by Application, 2019 – 2032
- Analgesics
- Anti-inflammatory Drug
- Cardiovascular Drugs
- Anti-diabetic Drugs
- Antimicrobial Drugs
- Anti-cancer Drugs
- Others
- Asia Pacific Pharmaceutical Intermediates Market Estimates (US$ Mn), by End User, 2019 – 2032
- Biotech and Pharma Companies
- Research Laboratory
- CMOs/CROs
- Asia Pacific Pharmaceutical Intermediates Market Estimates (US$ Mn), by Country, 2019 – 2032
- China
- Japan
- South Korea
- India
- Australia
- Rest of Asia Pacific
- Middle East & Africa Pharmaceutical Intermediates Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Middle East & Africa Pharmaceutical Intermediates Market Estimates (US$ Mn), by Product, 2019 – 2032
- Chemical Intermediates
- Bulk Drug Intermediates
- Chiral Intermediates
- Achiral Intermediates
- Custom Intermediates
- Middle East & Africa Pharmaceutical Intermediates Market Estimates (US$ Mn), by Application, 2019 – 2032
- Analgesics
- Anti-inflammatory Drug
- Cardiovascular Drugs
- Anti-diabetic Drugs
- Antimicrobial Drugs
- Anti-cancer Drugs
- Others
- Middle East & Africa Pharmaceutical Intermediates Market Estimates (US$ Mn), by End User, 2019 – 2032
- Biotech and Pharma Companies
- Research Laboratory
- CMOs/CROs
- Middle East & Africa Pharmaceutical Intermediates Market Estimates (US$ Mn), by Country, 2019 – 2032
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- South America Pharmaceutical Intermediates Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- South America Pharmaceutical Intermediates Market Estimates (US$ Mn), by Product, 2019 – 2032
- Chemical Intermediates
- Bulk Drug Intermediates
- Chiral Intermediates
- Achiral Intermediates
- Custom Intermediates
- South America Pharmaceutical Intermediates Market Estimates (US$ Mn), by Application, 2019 – 2032
- Analgesics
- Anti-inflammatory Drug
- Cardiovascular Drugs
- Anti-diabetic Drugs
- Antimicrobial Drugs
- Anti-cancer Drugs
- Others
- South America Pharmaceutical Intermediates Market Estimates (US$ Mn), by End User, 2019 – 2032
- Biotech and Pharma Companies
- Research Laboratory
- CMOs/CROs
- South America Pharmaceutical Intermediates Market Estimates (US$ Mn), by Country, 2019 – 2032
- Brazil
- Argentina
- Rest of South America
- Competition Analysis – Global Pharmaceutical Intermediates Market
- Market Composition
- Market Share Analysis (%), by Supplier (2022)
- Company Profiles
- BASF SE
- Business overview
- Geographic presence
- Product portfolio
- Financial facts
- Relevant news and strategic view
- Lonza Group
- Evonik Industries AG
- Cambrex Corporation
- DSM
- Aceto
- Albemarle Corporation
- Vertellus
- Chemcon Speciality Chemicals Ltd.
- Chiracon GmbH
- Life Sciences Private Limited
- BASF SE
- Conclusion & Recommendations
Frequently asked questions about this report
What is the pharmaceutical intermediates market growth?
The pharmaceutical intermediates market is expected to grow at a CAGR of 7.2% between 2023 to 2032.
What are the factors driving the pharmaceutical intermediates market?
The rising demand to treat chronic diseases increases the requirements of pharmaceutical intermediates. Additionally the demand for APIs in the coming years will also rise due to surging prevalence of infectious diseases which in turn will bolster the growth of the global pharmaceutical intermediate market.
What was the market for pharmaceutical intermediates valued at in 2021?
The pharmaceutical intermediates market size was estimated to be US$ 29.5 billion in 2021.
What are pharmaceutical intermediates?
The raw materials that are used in the production of bulk drugs are known as pharmaceutical intermediates. They are produced during the synthesis of active pharmaceutical ingredient (API) as a byproduct.
Who are the top players in the global pharmaceutical intermediates market?
Major players in the global pharmaceutical intermediates market are BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto, Albemarle, Corporation, Vertellus, Chemcon Speciality Chemicals Ltd., Chiracon GmbH, Life Sciences Private Limited and others.